207 related articles for article (PubMed ID: 35159369)
1. Induction of Survival of Motor Neuron (SMN) Protein Deficiency in Spinal Astrocytes by Small Interfering RNA as an In Vitro Model of Spinal Muscular Atrophy.
Leo M; Schmitt LI; Fleischer M; Steffen R; Osswald C; Kleinschnitz C; Hagenacker T
Cells; 2022 Feb; 11(3):. PubMed ID: 35159369
[TBL] [Abstract][Full Text] [Related]
2. Spinal astrocyte dysfunction drives motor neuron loss in late-onset spinal muscular atrophy.
Schmitt LI; David C; Steffen R; Hezel S; Roos A; Schara-Schmidt U; Kleinschnitz C; Leo M; Hagenacker T
Acta Neuropathol; 2023 May; 145(5):611-635. PubMed ID: 36930296
[TBL] [Abstract][Full Text] [Related]
3. Diminished motor neuron activity driven by abnormal astrocytic EAAT1 glutamate transporter activity in spinal muscular atrophy is not fully restored after lentiviral SMN delivery.
Welby E; Ebert AD
Glia; 2023 May; 71(5):1311-1332. PubMed ID: 36655314
[TBL] [Abstract][Full Text] [Related]
4. Spinal motor neuron loss occurs through a p53-and-p21-independent mechanism in the Smn
Reedich EJ; Kalski M; Armijo N; Cox GA; DiDonato CJ
Exp Neurol; 2021 Mar; 337():113587. PubMed ID: 33382987
[TBL] [Abstract][Full Text] [Related]
5. Decreased Motor Neuron Support by SMA Astrocytes due to Diminished MCP1 Secretion.
Martin JE; Nguyen TT; Grunseich C; Nofziger JH; Lee PR; Fields D; Fischbeck KH; Foran E
J Neurosci; 2017 May; 37(21):5309-5318. PubMed ID: 28450545
[TBL] [Abstract][Full Text] [Related]
6. SMN deficiency does not induce oxidative stress in SMA iPSC-derived astrocytes or motor neurons.
Patitucci TN; Ebert AD
Hum Mol Genet; 2016 Feb; 25(3):514-23. PubMed ID: 26643950
[TBL] [Abstract][Full Text] [Related]
7. Hyperexcitability precedes motoneuron loss in the
Quinlan KA; Reedich EJ; Arnold WD; Puritz AC; Cavarsan CF; Heckman CJ; DiDonato CJ
J Neurophysiol; 2019 Oct; 122(4):1297-1311. PubMed ID: 31365319
[TBL] [Abstract][Full Text] [Related]
8. Loganin possesses neuroprotective properties, restores SMN protein and activates protein synthesis positive regulator Akt/mTOR in experimental models of spinal muscular atrophy.
Tseng YT; Chen CS; Jong YJ; Chang FR; Lo YC
Pharmacol Res; 2016 Sep; 111():58-75. PubMed ID: 27241020
[TBL] [Abstract][Full Text] [Related]
9. Astrocytes influence the severity of spinal muscular atrophy.
Rindt H; Feng Z; Mazzasette C; Glascock JJ; Valdivia D; Pyles N; Crawford TO; Swoboda KJ; Patitucci TN; Ebert AD; Sumner CJ; Ko CP; Lorson CL
Hum Mol Genet; 2015 Jul; 24(14):4094-102. PubMed ID: 25911676
[TBL] [Abstract][Full Text] [Related]
10. Calpain Inhibition Increases SMN Protein in Spinal Cord Motoneurons and Ameliorates the Spinal Muscular Atrophy Phenotype in Mice.
de la Fuente S; Sansa A; Periyakaruppiah A; Garcera A; Soler RM
Mol Neurobiol; 2019 Jun; 56(6):4414-4427. PubMed ID: 30327977
[TBL] [Abstract][Full Text] [Related]
11. Notch Signaling Mediates Astrocyte Abnormality in Spinal Muscular Atrophy Model Systems.
Ohuchi K; Funato M; Yoshino Y; Ando S; Inagaki S; Sato A; Kawase C; Seki J; Saito T; Nishio H; Nakamura S; Shimazawa M; Kaneko H; Hara H
Sci Rep; 2019 Mar; 9(1):3701. PubMed ID: 30842449
[TBL] [Abstract][Full Text] [Related]
12. Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice.
Tsai LK; Tsai MS; Ting CH; Li H
J Mol Med (Berl); 2008 Nov; 86(11):1243-54. PubMed ID: 18649067
[TBL] [Abstract][Full Text] [Related]
13. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of the Survival of Motor Neuron Protein Impairs mRNA Localization and Local Translation in the Growth Cone of Motor Neurons.
Fallini C; Donlin-Asp PG; Rouanet JP; Bassell GJ; Rossoll W
J Neurosci; 2016 Mar; 36(13):3811-20. PubMed ID: 27030765
[TBL] [Abstract][Full Text] [Related]
15. Skeletal muscle DNA damage precedes spinal motor neuron DNA damage in a mouse model of Spinal Muscular Atrophy (SMA).
Fayzullina S; Martin LJ
PLoS One; 2014; 9(3):e93329. PubMed ID: 24667816
[TBL] [Abstract][Full Text] [Related]
16. CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis.
Janzen E; Mendoza-Ferreira N; Hosseinibarkooie S; Schneider S; Hupperich K; Tschanz T; Grysko V; Riessland M; Hammerschmidt M; Rigo F; Bennett CF; Kye MJ; Torres-Benito L; Wirth B
Brain; 2018 Aug; 141(8):2343-2361. PubMed ID: 29961886
[TBL] [Abstract][Full Text] [Related]
17. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model.
Hua Y; Sahashi K; Rigo F; Hung G; Horev G; Bennett CF; Krainer AR
Nature; 2011 Oct; 478(7367):123-6. PubMed ID: 21979052
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological properties of motor neurons in a mouse model of severe spinal muscular atrophy: in vitro versus in vivo development.
Zhang H; Robinson N; Wu C; Wang W; Harrington MA
PLoS One; 2010 Jul; 5(7):e11696. PubMed ID: 20657731
[TBL] [Abstract][Full Text] [Related]
19. A large animal model of spinal muscular atrophy and correction of phenotype.
Duque SI; Arnold WD; Odermatt P; Li X; Porensky PN; Schmelzer L; Meyer K; Kolb SJ; Schümperli D; Kaspar BK; Burghes AH
Ann Neurol; 2015 Mar; 77(3):399-414. PubMed ID: 25516063
[TBL] [Abstract][Full Text] [Related]
20. Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene.
Park GH; Maeno-Hikichi Y; Awano T; Landmesser LT; Monani UR
J Neurosci; 2010 Sep; 30(36):12005-19. PubMed ID: 20826664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
